Next quarter’s earnings estimate for CNTB is -$0.72 with a range of -$0.95 to -$0.59. The previous quarter’s EPS was -$0.54. CNTB beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.63% of the time in the same period. In the last calendar year CNTB has Underperformed its overall industry.

No data currently available

CNTB Sales Forecast

Next quarter’s sales forecast for CNTB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CNTB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.60% of the time in the same period. In the last calendar year CNTB has Underperformed its overall industry.

CNTB Analyst Recommendation Trends

CNTB has not received any ratings in the last 3 months.

Detailed List of Analyst Forecasts

Thomas Smith

Leerink Partners

―

Buy

―

Reiterated

2023-06-01

Connect Biopharma Holdings (CNTB) Receives a Rating Update from a Top Analyst

Kelly Shi

Jefferies

$7.00

Buy

614.29%

Upside

Reiterated

2022-10-05

Connect Biopharma Holdings (CNTB) Receives a Buy from Jefferies

Best Analysts Covering Connect Biopharma Holdings

Which Analyst Should I Follow If I Want to Buy CNTB and Sell After:

1 Month

Thomas SmithLeerink Partners

Success Rate

5/13 ratings generated profit

Average Return

-13.63%

reiterated a buy rating 4 months ago

Copying Thomas Smith's trades and holding each position for 1 Month would result in 38.46% of your transactions generating a profit, with an average return of -13.63% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

Go Premium

3 Months

Thomas SmithLeerink Partners

Success Rate

5/13 ratings generated profit

Average Return

-25.73%

reiterated a buy rating 4 months ago

Copying Thomas Smith's trades and holding each position for 3 Months would result in 38.46% of your transactions generating a profit, with an average return of -25.73% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

Go Premium

1 Year

Thomas SmithLeerink Partners

Success Rate

2/13 ratings generated profit

Average Return

-48.68%

reiterated a buy rating 4 months ago

Copying Thomas Smith's trades and holding each position for 1 Year would result in 15.38% of your transactions generating a profit, with an average return of -48.68% per trade.

2 Years

Thomas SmithLeerink Partners

Success Rate

0/13 ratings generated profit

Average Return

-58.57%

reiterated a buy rating 4 months ago

Copying Thomas Smith's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -58.57% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

Go Premium

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxxxxxxxxxxxxxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CNTB Stock Forecast FAQ

What is CNTB’s average 12-month price target, according to analysts?

Currently, no data Available

What is CNTB’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CNTB, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CNTB a Buy, Sell or Hold?

Currently, no data Available

What is Connect Biopharma Holdings’s price target?

Currently, no data Available

What do analysts say about Connect Biopharma Holdings?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of CNTB?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Connect Biopharma Holdings (CNTB) Stock Forecast & Price Target

CNTB Analyst Ratings

CNTB Stock 12 Months Forecast

CNTB Financial Forecast

CNTB Earnings Forecast

CNTB Sales Forecast

CNTB Analyst Recommendation Trends

Detailed List of Analyst Forecasts​

Best Analysts Covering Connect Biopharma Holdings

CNTB Stock Forecast FAQ

Get More with TipRanks Premium

Detailed List of Analyst Forecasts